Linezolid Oral Tablet

DRUG3 trials

Sponsors

Wits Health Consortium (Pty) Ltd, Fundacion Clinic per a la Recerca Biomédica, Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

Conditions

Cutaneous UlcerEndocarditis InfectiveExtensively Drug-Resistant TuberculosisMulti Drug Resistant TuberculosisPre-XDR-TBRifampicin Resistant TuberculosisTuberculosisYaws

Phase 3

Building Evidence for Advancing New Treatment for Rifampicin Resistant Tuberculosis (RR-TB) Comparing a Short Course of Treatment (Containing Bedaquiline, Delamanid and Linezolid) With the Current South African Standard of Care

CompletedNCT04062201

Wits Health Consortium (Pty) LtdExtensively Drug-Resistant Tuberculosis, Multi Drug Resistant Tuberculosis, Pre-XDR-TB +2

Start: 2019-08-22End: 2024-04-15Updated: 2024-08-28

Repurposing Clinically Approved Drugs for Yaws with an Insight Into the Cutaneous Ulcer Disease Syndrome (Trep-AByaws)

CompletedNCT05764876

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la CienciaCutaneous Ulcer, Yaws

Start: 2023-03-14End: 2024-12-01Updated: 2025-01-09

Phase 4

Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

RecruitingNCT05398679

Fundacion Clinic per a la Recerca BiomédicaEndocarditis Infective

Start: 2022-08-17End: 2027-12-30Target: 360Updated: 2026-02-25

Related Papers

Oral vs. Outpatient Parenteral Antimicrobial Treatment for Infective Endocarditis: Study Protocol for the Spanish OraPAT-IE GAMES Trial

Infectious Diseases and Therapy2025-03-014 citations